Publications by authors named "D M Khalilova"

Article Synopsis
  • * Participants, averaging 54.6 years old, showed a variety of PCS symptoms, such as fatigue, decreased memory, and sleep issues, with 30% of neurological admissions attributed to PCS, but no link was found between symptom severity and COVID-19 severity.
  • * Cortexin treatment effectively addressed cognitive and asthenic symptoms of PCS, demonstrating notable anti-anxiety and antidepressant effects, especially at the higher 20 mg dosage. *
View Article and Find Full Text PDF

Objective: To study the prevalence of clinical manifestations of postcoid syndrome in patients at an outpatient neurological appointment, to evaluate the effectiveness of therapy regimens using Cortexin at doses of 10 mg and 20 mg IM for 10 days.

Materials And Methods: 674 neurologists from all regions of the Russian Federation, Azerbaijan, Kyrgyzstan and Kazakhstan took part in the study. A total of 979 COVID-19 patients were recruited.

View Article and Find Full Text PDF